Kamal Therapeutics, Inc. — Form D
Kamal Therapeutics, Inc. of HINGHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-27. The offering totals $10.0M, of which $4.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-08-27
- Form: D
- Accession: 0001880064-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $4.3M
- Remaining: $5.7M
- Investors: 25
- Date of first sale: 2021-08-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-411476
Issuer
- Name: Kamal Therapeutics, Inc.
- CIK: 0001880064
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 66 CLUBHOUSE DRIVE, HINGHAM, MA, 02043
- Phone: 857 222 4653
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Mark de Souza | Director | Hingham, MA |
| Mark de Souza | Executive Officer | Hingham, MA |
| Philip Reilly | Director | Hingham, MA |
| John Parker | Director | Hingham, MA |
| Alexander Silver | Director | New York, NY |
| Hal Landy | Director | Hingham, MA |
| Joff Masukawa | Director | Hingham, MA |
| Deborah Ramsdell | Director | Hingham, MA |
| Deborah Ramsdell | Executive Officer | Hingham, MA |
| Mark P de Souza | Director | Emeryville, CA |
Other filings by this issuer (2)
More